Infection-Related Malignant Neoplasm — Trials

Infection-Related Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

539 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 133
Recruiting: 71
Ph III recruiting: 2
Growth YoY: −24%
Industry share: 17%
Top sponsor: National Cancer Institute (NCI)
Termination share: 30.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (75)

clinicaltrialsPublishedShowing 1–41 of 41 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05907759	Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease	recruiting	Phase 2	40	National Cancer Institute (NCI)NIH	1	Sep 25, 2026	clinicaltrials
NCT06949800	CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial	recruiting	Phase 2	90	University of California, San FranciscoOTHER	2	Sep 15, 2026	clinicaltrials